Replies to post #87567 on Amarantus Bioscience Holdings Inc (AMBS)

[blackhawks]

BH, ask Gerald

this is his below quote - not mine - as predicated on his valuations - not on a JV - not on product sales - but of an Acquisition, aka buyout offer:

"We think this represents a $300-Mil. opportunity and a potential acquisition"

The fact that I use quotes sometimes doesn't appear to matter. My response to you was a response to the quote below that you used in your post. As you can read, from what you chose to quote, Gerald appears to predicate a buy-out on the 'ramp up' of actual sales $.

Do you know if the quote below appeared in the presentation after the one above and therefore amplified, clarified the 'opportunity' quote?

The greater specificity, the predicate of sales $ before buy-out, certainly suggests it's a later statement, a qualification, an amplification.

If I were in the audience and taking notes, I would certainly take the quote below to be the 'money shot', quite literally, on what it would take to attract a buy-out of AMBS Diagnostics.

So if we ramp up to $3, $4, $5, $10-Mil. in sales, you can expect to see a 10 times sales, 15 times sales, or a 20 times sales buy-out of our technology"